The international PhD Program Bioengineering – Cell Therapies and Regenerative Medicine combines academic research with 3 complementary dimensions: Clinical, Industrial and International.

 

MD’s with vast clinical experience will contribute to training and supervision of students, allowing their access to clinical environment (Hospital de Santa Marta - Cardiology, Hospital de Santa Maria - Hematology, Hospital Garcia de Orta - Urology, Hospital Egas Moniz – Orthopedics, Otorrinolaryngology, Neurology, Instituto Português de Oncologia Francisco Gentil, Lisboa – Bone Marrow Transplantation, Hospital Curry Cabral – Intensive Care, Hospital Fernando Fonseca – Medicine IV, Hospital de São José - Pathology).

 

Several companies that pioneered the field of Regenerative Medicine in Portugal will contribute directly to training and supervision of students, as well as to host students in laboratory rotations.

 

ECBio – I&D em Biotecnologia, S.A.

 

Crioestaminal – Saúde e Tecnologia, S.A.

 

Ceramed – Medical Coatings

 

TCLab

 

Cell2B – Advanced Therapeutics

 

GenIBET-Biopharmaceuticals

 

The PhD Program is supported by a strong international network of top research groups, located in Europe and North America, and industrial affiliates that might host students for 6 to 18 months of their PhD studies. The participating international faculty and entrepreneurs are committed to provide lectures, host and co-supervise students.

 

Europe

 

University College London, UK

 

Loughborough University, UK

 

National Institute of Bioprocess Research and Training, Ireland

 

University of Padova and Venetian Institute of Molecular Medicine, Italy

 

 

USA

 

University of California, Berkeley

 

Georgia Institute of Technology

 

University of Wisconsin

 

University of Minnesota

 

Wake Forest Institute for Regenerative Medicine

 

Northwestern University

 

Tulane University

 

 

Canada

 

University of Toronto

 

University of British Columbia